|Original language||English (US)|
|Number of pages||2|
|Journal||JAMA - Journal of the American Medical Association|
|State||Published - Jan 12 2021|
ASJC Scopus subject areas
Access to Document
Other files and links
Postoperative Atrial Fibrillation after Noncardiac Surgery and Stroke - Reply. / Siontis, Konstantinos C.; Gersh, Bernard J.; Chamberlain, Alanna M.In: JAMA - Journal of the American Medical Association, Vol. 325, No. 2, 12.01.2021, p. 187-188.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Postoperative Atrial Fibrillation after Noncardiac Surgery and Stroke - Reply
AU - Siontis, Konstantinos C.
AU - Gersh, Bernard J.
AU - Chamberlain, Alanna M.
N1 - Funding Information: Corresponding Author: Alanna M. Chamberlain, PhD, Department of Health Sciences Research, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (firstname.lastname@example.org). Conflict of Interest Disclosures: Dr Chamberlain reported receipt of grants from the National Institute on Aging. No other disclosures were reported. 1. Siontis KC, Gersh BJ, Weston SA, et al. Association of new-onset atrial fibrillation after noncardiac surgery with subsequent stroke and transient ischemic attack. JAMA. 2020;324(9):871-878. doi:10.1001/jama.2020.12518 2. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest. 2010;137(2):263-272. doi:10.1378/chest.09-1584 Funding Information: Conflict of Interest Disclosures: Dr Arterburn reported receiving grants from the National Institute of Diabetes and Digestive and Kidney Diseases and the Patient-Centered Outcomes Research Institute and personal fees from the International Federation for the Surgery of Obesity and Metabolic Disorders Latin American Chapter and the World Congress for Interventional Therapy for Diabetes. Dr Courcoulas reported receiving grants from the National Institute of Diabetes and Digestive and Kidney Diseases, the Patient-Centered Outcomes Research Institute, Allurion, and Covidien/Ethicon. No other disclosures were reported.
PY - 2021/1/12
Y1 - 2021/1/12
UR - http://www.scopus.com/inward/record.url?scp=85099605638&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099605638&partnerID=8YFLogxK
U2 - 10.1001/jama.2020.22484
DO - 10.1001/jama.2020.22484
M3 - Letter
C2 - 33433571
AN - SCOPUS:85099605638
VL - 325
SP - 187
EP - 188
JO - JAMA - Journal of the American Medical Association
JF - JAMA - Journal of the American Medical Association
SN - 0002-9955
IS - 2